December 6, 2024 - 02:43

Sari Altschuler, a professor of English, raises concerns about the implications of employing AI scribes for medical note-taking. While the technology promises efficiency and time-saving benefits for healthcare professionals, Altschuler argues that it may inadvertently compromise the quality of patient care.
AI scribes are designed to automate the documentation process, allowing physicians to focus more on patient interaction. However, Altschuler points out that reliance on artificial intelligence for such critical tasks could lead to a decline in the depth and accuracy of medical records. The nuances of patient interactions might be lost in translation, resulting in a less personalized approach to healthcare.
Moreover, the professor emphasizes that the human element in medical documentation is irreplaceable. Physicians often rely on their instincts and understanding of patient history, which AI may not fully capture. As healthcare continues to evolve with technology, the balance between efficiency and quality remains a key concern for practitioners and patients alike.
April 20, 2026 - 12:23
He started pickleball as a hobby — now, at 82, it's his second careerAt 82 years young, Robert Warden has discovered an unexpected second wind, turning a casual hobby into a vibrant new chapter. His journey began in retirement, not with a grand plan, but from a...
April 19, 2026 - 18:17
Trump admin seeks health-care price transparencyA new push for price transparency within federal employee health plans is drawing praise from taxpayer advocates and criticism from healthcare industry leaders. The initiative, championed by the...
April 19, 2026 - 10:47
Pioneering Genetic Researchers Awarded $3 Million for Sickle Cell Cure FoundationDr. Swee Lay Thein and Dr. Stuart Orkin have been honored with the prestigious $3 million Breakthrough Prize in Life Sciences. The award recognizes their decades of foundational research that...
April 18, 2026 - 06:22
Trump Expected to Loosen Restrictions on Psychedelic DrugsA new executive order is poised to significantly reduce federal restrictions on research involving psychedelic compounds. The directive aims to accelerate scientific studies into the potential...